Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

VIGL - Vigil Neuroscience, Inc. Stock Price, Fair Value and News

$2.13-0.22 (-9.36%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

VIGL Price Action

Last 7 days

-0.8%

Last 30 days

-11.3%

Last 90 days

17.5%

Trailing 12 Months

-21.1%

VIGL Stock Price

VIGL RSI Chart

JunJulAugSepOctNovDec2025FebMar0102030405060708090

VIGL Valuation

Market Cap

96.1M

Price/Earnings (Trailing)

-1.16

Price/Free Cashflow

-2.96

VIGL Price/Earnings (Trailing)

202320242025-8-6-4-20

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VIGL Fundamentals

VIGL Earnings

Earnings (TTM)

-82.6M

Earnings Growth (Yr)

6.04%

Earnings Growth (Qtr)

9.28%

202220232024-80M-70M-60M-50M-40M

VIGL Profitability

Return on Equity

-93.28%

Return on Assets

-62.92%

Free Cashflow Yield

-33.76%

VIGL Investor Care

Shares Dilution (1Y)

13.94%

Diluted EPS (TTM)

-2.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs

About Vigil Neuroscience, Inc.

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101, a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also conducting IND-enabling studies with a novel small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Watertown, Massachusetts.
 CEO
 WEBSITEvigilneuro.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES61

Vigil Neuroscience, Inc. Frequently Asked Questions

What is the ticker symbol for Vigil Neuroscience, Inc.? What does VIGL stand for in stocks?

VIGL is the stock ticker symbol of Vigil Neuroscience, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Vigil Neuroscience, Inc. (VIGL)?

As of Wed Mar 12 2025, market cap of Vigil Neuroscience, Inc. is 96.07 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VIGL stock?

You can check VIGL's fair value in chart for subscribers.

Is Vigil Neuroscience, Inc. a good stock to buy?

The fair value guage provides a quick view whether VIGL is over valued or under valued. Whether Vigil Neuroscience, Inc. is cheap or expensive depends on the assumptions which impact Vigil Neuroscience, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VIGL.